Structure of the p300 Histone Acetyltransferase Bound to Acetyl-Coenzyme A and Its Analogues-Reference-Cited by-同舟云学术

Structure of the p300 Histone Acetyltransferase Bound to Acetyl-Coenzyme A and Its Analogues

Published:2014-05-21 Issue:21 Volume:53 Page:3415-3422
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Maksimoska Jasna¹²,Segura-Peña Dario¹,Cole Philip A.³,Marmorstein Ronen¹²

Affiliation:

1. Program in Gene Expression and Regulation, The Wistar Institute, 3601 Spruce Street, Philadelphia, Pennsylvania 19104, United States

2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

3. Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, United States

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi500380f

Reference33 articles.

1. Phosphorylated CREB binds specifically to the nuclear protein CBP

2. The CBP co-activator is a histone acetyltransferase

3. The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases

4. Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment;Pharmacology & Therapeutics;2024-05

2. Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader;Nucleic Acids Research;2024-03-21

3. Spray-type modifications: an emerging paradigm in post-translational modifications;Trends in Biochemical Sciences;2024-03

4. Robinetin Alleviates Metabolic Failure in Liver through Suppression of p300-CD38 Axis;Biomolecules & Therapeutics;2024-02-01

5. Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer;European Journal of Medicinal Chemistry;2024-02